![]()
Segment / Product Line Reporting Changes - New! To better reflect how Hospira currently manages its business, as well as its strategic focus on certain product lines, beginning in the first quarter of 2008 we are re-aligning our segment and product line reporting presentation. Click here to view the historical quarterly net sales for 2007 and 2006 re-cast under these new categories. Please note that 2007’s net sales include 11 months of Mayne Pharma Limited’s net sales classified in the appropriate product line; Mayne is not broken out separately. The net sales for 2006 do not include Mayne’s sales. Corporate Profile
Shareholder E-Delivery Are you a Hospira shareholder? If so, you can elect to receive your annual report, proxy statement and other investor-related materials online, reducing the amount of mailings you receive from us. Using Shareholder E-Delivery also promotes less paper usage, a more environmentally friendly practice, and helps reduce company costs. If this is an option that interests you, sign up today! |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This Web site and its information is intended for
use by United States residents only. Countries outside the United States may
have regulatory requirements, data requirements or medical practices that
differ from the United States and, therefore, this information may be
inappropriate for use outside the United States. Site contents are intended for
informational purposes only and not intended to replace discussion with a
healthcare provider. If you have any questions regarding this site,
contact Hospira. 9-084-IR |